Recipharm invests USD 2.5 million in clinical GMP capacity for active pharmaceutical ingredients
Global contract development and manufacturing organisation (CDMO), Recipharm, has announced an investment and capacity expansion at its facility in Israel. This investment will support…
Read More...
Read More...
